Literature DB >> 9366394

T cells from Jak3-deficient mice have intact TCR signaling, but increased apoptosis.

D C Thomis1, W Lee, L J Berg.   

Abstract

The Jak family tyrosine kinase, Jak3, is involved in signaling through cytokine receptors utilizing the common gamma-chain (gamma(c)). Mice and humans lacking Jak3 have severe immune deficiencies, including defects in B and T lymphocyte development and function. In particular, Jak3-deficient mice have mature T cells with an activated phenotype, yet these cells are functionally nonresponsive. In this work, we show that Jak3-deficient T cells have no gross defects in early T cell signaling, as measured by TCR-induced tyrosine phosphorylation and calcium mobilization responses. Furthermore, we find that Jak3-deficient mice expressing a transgenic TCR have extremely low numbers of peripheral T cells with a naive phenotype, indicating that both peripheral activation and expansion of Jak3-/- T cells are driven by antigenic signals. We show that, similar to gamma(c)-deficient mice, T cells from Jak3-deficient mice have an increased susceptibility to apoptosis. Previously, we showed that when stimulated in vitro by CD3 plus CD28 cross-linking, Jak3-/- T cells secrete greatly reduced amounts of IL-2, and fail to proliferate. However, by measuring intracellular IL-2 levels, we find that Jak3-/- T cells produce amounts of IL-2 similar to activated T cells from control mice, further supporting the notion that there is no defect in TCR signaling in Jak3-/- T cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9366394

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Jak3 selectively regulates Bax and Bcl-2 expression to promote T-cell development.

Authors:  R Wen; D Wang; C McKay; K D Bunting; J C Marine; E F Vanin; G P Zambetti; S J Korsmeyer; J N Ihle; J L Cleveland
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

2.  The MAR-binding protein SATB1 orchestrates temporal and spatial expression of multiple genes during T-cell development.

Authors:  J D Alvarez; D H Yasui; H Niida; T Joh; D Y Loh; T Kohwi-Shigematsu
Journal:  Genes Dev       Date:  2000-03-01       Impact factor: 11.361

Review 3.  Janus kinase 3: the controller and the controlled.

Authors:  Wei Wu; Xiao-Hong Sun
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2011-11-29       Impact factor: 3.848

4.  Partial trisomy 21 contributes to T-cell malignancies induced by JAK3-activating mutations in murine models.

Authors:  Paola Rivera-Munoz; Anouchka P Laurent; Aurelie Siret; Cecile K Lopez; Cathy Ignacimouttou; Melanie G Cornejo; Olivia Bawa; Philippe Rameau; Olivier A Bernard; Philippe Dessen; Gary D Gilliland; Thomas Mercher; Sébastien Malinge
Journal:  Blood Adv       Date:  2018-07-10

5.  Autocrine release of interleukin-9 promotes Jak3-dependent survival of ALK+ anaplastic large-cell lymphoma cells.

Authors:  Lin Qiu; Raymond Lai; Quan Lin; Esther Lau; David M Thomazy; Daniel Calame; Richard J Ford; Larry W Kwak; Robert A Kirken; Hesham M Amin
Journal:  Blood       Date:  2006-06-08       Impact factor: 22.113

Review 6.  Janus kinases in immune cell signaling.

Authors:  Kamran Ghoreschi; Arian Laurence; John J O'Shea
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

Review 7.  T cell signaling and apoptosis in HIV disease.

Authors:  Nithianandan Selliah; Jason Shackelford; Jiang-Fang Wang; Frank Traynor; Jiyi Yin; Terri H Finkel
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

8.  Impaired chemokine-induced migration during T-cell development in the absence of Jak 3.

Authors:  Gloria Soldevila; Ileana Licona; Alfonso Salgado; Marcela Ramírez; Ramsés Chávez; Eduardo García-Zepeda
Journal:  Immunology       Date:  2004-06       Impact factor: 7.397

9.  Janus-kinase-3-dependent signals induce chromatin remodeling at the Ifng locus during T helper 1 cell differentiation.

Authors:  Min Shi; Tsung H Lin; Kenneth C Appell; Leslie J Berg
Journal:  Immunity       Date:  2008-06       Impact factor: 31.745

10.  Effect of Janus kinase 3 on the peptide transporters PEPT1 and PEPT2.

Authors:  Jamshed Warsi; Zohreh Hosseinzadeh; Luo Dong; Tatsiana Pakladok; Anja T Umbach; Shefalee K Bhavsar; Ekaterina Shumilina; Florian Lang
Journal:  J Membr Biol       Date:  2013-08-10       Impact factor: 1.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.